SCHEMBL21929616

SCHEMBL21929616

N#Cc1ccc(-c2ccccc2-c2ccccc2N2c3ccccc3Sc3ccccc32)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN2 Q96KS0 1/20 0.39
ALDH1A1 P00352 5/20 0.34
KDM4E B2RXH2 3/20 0.34
HPGD P15428 3/20 0.34
HTT P42858 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 4/20 0.33
LMNA P02545 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
TP53 P04637 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GRM5 P41594 2/20 0.33
AR P10275 1/20 0.33
MAPK1 P28482 2/20 0.32
PGR P06401 1/20 0.32
CHRM2 P08172 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32
CHRM1 P11229 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21927642 0.95 EGLN2 (0.40) EGLN2ALDH1A1KDM4EHPGDHTT
SCHEMBL21927944 0.88 KDM4E (0.43) EGLN2ALDH1A1KDM4EHPGDHTT
SCHEMBL21927652 0.84 EGLN2 (0.38) EGLN2ALDH1A1KDM4EHPGDHTT
SCHEMBL21927261 0.83 EGLN2 (0.37) EGLN2ALDH1A1KDM4EHPGDHTT
SCHEMBL21927267 0.83 EGLN2 (0.39) EGLN2ALDH1A1KDM4EHPGDHTT
SCHEMBL21927287 0.82 EGLN2 (0.39) EGLN2ALDH1A1KDM4EHPGDHTT
SCHEMBL21929614 0.81 HCRTR1 (0.34) ALDH1A1KDM4EHTTMAPTLMNA
SCHEMBL21928001 0.80 PGR (0.40) EGLN2ALDH1A1KDM4EHPGDHTT
SCHEMBL21928018 0.79 EGLN2 (0.36) EGLN2ALDH1A1KDM4EHPGDHTT
SCHEMBL21927379 0.77 EGLN2 (0.41) EGLN2ALDH1A1KDM4EHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200131150-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131150-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE SAME AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CCNT1, CCNA1, CCNE2 EGLN2 3494/4885ALDH1A1 511/4885KDM4E 3872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.